Achilles Therapeutics

-$0.12 (-0.84%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ACHL and other stocks, options, and ETFs commission-free!

About ACHL

Achilles Therapeutics plc American Depositary Shares, also called Achilles Therapeutics, is a biopharmaceutical company engages in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens.

CEO
Iraj Ali
Employees
159
Headquarters
London, Greater London
Founded
2020

ACHL Key Statistics

Market Cap
642.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
51.94K
High Today
$16.00
Low Today
$13.62
Open Price
$14.76
Volume
16.13K
52 Week High
$18.95
52 Week Low
$12.63

ACHL Earnings

Q1 FY21
Estimated
— per share
Actual
Expected May 18, Pre-Market

You May Also Like

SOAC+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure